The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Global prospective cohort study of factors associated with early mortality in patients with lung cancer undergoing chemotherapy.
 
Nicole Maria Kuderer
Consulting or Advisory Role - Daiichi Sankyo; Hospira; Janssen
Research Funding - Amgen (I)
Travel, Accommodations, Expenses - Daiichi Sankyo; Hospira; Janssen
 
Marek S. Poniewierski
No Relationships to Disclose
 
Eva Culakova
Research Funding - Amgen (Inst)
 
Gary H. Lyman
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo (I)
 
Alok A. Khorana
Honoraria - AngioDynamics; Boehringer Ingelheim; Daiichi Sankyo; Genentech; Halozyme; Janssen; LEO Pharma; Pfizer; Sanofi
Consulting or Advisory Role - AngioDynamics; Boehringer Ingelheim; Daiichi Sankyo; Genentech; Halozyme; Janssen; LEO Pharma; Sanofi
Research Funding - Amgen (Inst); LEO Pharma
Travel, Accommodations, Expenses - AngioDynamics; Halozyme; Janssen
 
Ingrid Pabinger
No Relationships to Disclose
 
Giancarlo Agnelli
No Relationships to Disclose
 
Howard A. Liebman
Honoraria - Genzyme; Novartis
Consulting or Advisory Role - Janssen
Speakers' Bureau - Alexion Pharmaceuticals (I)
Research Funding - Amgen; Bristol-Myers Squibb
 
Eric Vicaut
No Relationships to Disclose
 
Guy Meyer
Research Funding - Bayer; Boehringer Ingelheim; LEO Pharma
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Daiichi Sankyo; LEO Pharma
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Merck/Schering Plough; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Recombio; Synta
Research Funding - Boehringer Ingelheim (Inst)